Status:
COMPLETED
Treatment of Zollinger-Ellison Syndrome With Prevacid
Lead Sponsor:
Charles Mel Wilcox, MD
Collaborating Sponsors:
Takeda Pharmaceuticals North America, Inc.
Conditions:
Zollinger-Ellison Syndrome
Multiple Endocrine Neoplasia
Eligibility:
All Genders
19+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to study the safety and efficacy of high dose Prevacid in the long-term treatment of patients who secrete abnormally large amounts of gastric acid.
Detailed Description
The aim of this protocol is to study the medical management of acid hypersecretory states including Zollinger-Ellison using Prevacid. The immediate objective is to heal peptic ulcers and eliminate sym...
Eligibility Criteria
Inclusion
- Diagnosed with Zollinger-Ellison syndrome
Exclusion
- Pregnant or lactating females
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00204373
Start Date
March 1 2003
End Date
December 1 2010
Last Update
October 30 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.